1 / 1

Clopidogrel in Cardiovascular Disease: Insights from Phase III Trials

Explore the impact of platelet ADP-receptor antagonists like clopidogrel in cardiovascular disease through a review of phase III randomized trials. Learn about their past, present, and future applications in managing cardiovascular conditions.

len-cantu
Télécharger la présentation

Clopidogrel in Cardiovascular Disease: Insights from Phase III Trials

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 4 Summary of phase III, randomized, controlled trials with clopidogrel in cardiovascular disease; part 2 Raju NC et al. (2008) Platelet ADP-receptor antagonists for cardiovascular disease: past, present and futureNat Clin Pract Cardiovasc Med doi:10.1038/ncpcardio1372

More Related